0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer

Clinical trial NCT00771953 · COMPLETED

Trial details

NCT number: NCT00771953
Sponsor: University of Maryland, Baltimore
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non Small Cell Lung Cancer

Start date: 2008-11-01
Primary completion: 2012-05-01
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.